07:23 AM EDT, 10/08/2024 (MT Newswires) -- Pfizer ( PFE ) and BioNTech (BNTX) successfully invalidated two patents held by CureVac ( CVAC ) in a ruling by London's High Court on Tuesday.

The lawsuit, filed in September 2022, relates to messenger RNA technology used in their COVID-19 vaccine.

"The decision of the UK Court is an important one as we believe that these patents do not meet the requirements for patentability and should never have been granted," said a BioNTech spokesperson.

Pfizer ( PFE ) and CureVac ( CVAC ) did not immediately respond to MT Newswires' request for comment.

Price: 29.32, Change: +0.12, Percent Change: +0.41